Search results for "time factor"

showing 10 items of 3219 documents

Kinetics of echinostoma caproni (trematoda: echinostomatidae) antigens in feces and serum of experimentally infected hamsters and rats

2004

This study reports on the kinetics of antibody production to Echinostoma caproni and the dynamics of antigens in feces and sera in 2 experimental hosts (hamsters and rats) that display different degrees of susceptibility with this echinostome. Echinostoma caproniproduced chronic infections in hamsters, whereas rats lost the infection at 49-56 days postinfection (DPI). Hamsters developed higher antibody responses than rats, probably in relation to different intestinal absorptions of worm antigens in each host species. The levels of coproantigens were indicative of the course of infection in each host. Positive coproantigen levels were detected at 1-2 DPI in both hosts, and the values remaine…

MaleTime FactorsAntibodies HelminthHamsterEchinostoma caproniEnzyme-Linked Immunosorbent Assay:CIENCIAS DE LA VIDA [UNESCO]MicrobiologyEchinostomatidaeFecesAntigenCricetinaeEchinostomaUNESCO::CIENCIAS DE LA VIDAAnimalsParasite hostingAntigensRats WistarEcology Evolution Behavior and SystematicsFecesEchinostomiasisMesocricetusbiology:CIENCIAS DE LA VIDA::Biología animal (Zoología) ::Parasitología animal [UNESCO]Tissue migrationbiology.organism_classificationRatsEchinostoma caproni ; Antigens ; Hamsters ; RatsKineticsUNESCO::CIENCIAS DE LA VIDA::Biología animal (Zoología) ::Parasitología animalAntigens HelminthImmunologyHamstersParasitologyTrematodaEchinostoma
researchProduct

Fenofibrate effect on triglyceride and postprandial response of apolipoprotein A5 variants: the GOLDN study.

2007

Objective— Apolipoprotein A5 ( APOA5 ) is a key determinant of plasma triglyceride (TG) concentrations. Genetic variation at the APOA5 locus could be responsible for some of the observed differences in response to fenofibrate therapy. Methods and Results— We examined the association between tag SNPs (−1131T>C and 56C>G) at APOA5 and TG and HDL-C response to fenofibrate and a postprandial lipid challenge in 791 men and women participating in the GOLDN study. After 3-week drug treatment, APOA5 56G carriers displayed significant decrease in TG ( P =0.006), and increase in HDL-C ( P =0.002) levels relative to their basal values in the fasting state when compared with noncarriers (a TG re…

MaleTime FactorsApolipoprotein BAdministration Oralchemistry.chemical_compoundFenofibrateGene FrequencyApolipoprotein a5Hypolipidemic AgentsAged 80 and overFenofibratebiologyMiddle AgedPostprandial PeriodPostprandialTreatment OutcomeArea Under CurveFemaleCardiology and Cardiovascular Medicinemedicine.drugAdultmedicine.medical_specialtyGuanineAdolescentGenotypeSingle-nucleotide polymorphismHyperlipidemiasPolymorphism Single NucleotideCytosineInternal medicinemedicineHumansParticle SizeApolipoproteins ATriglyceridesAgedTriglyceridebusiness.industryCholesterolCholesterol HDLCholesterol LDLDrug interactionLipid MetabolismDietary FatsUnited StatesEndocrinologychemistryApolipoprotein A-Vbiology.proteinbusinessThymineArteriosclerosis, thrombosis, and vascular biology
researchProduct

Plasma membrane Ca2+ ATPase 4 is required for sperm motility and male fertility.

2004

Calcium and Ca(2+)-dependent signals play a crucial role in sperm motility and mammalian fertilization, but the molecules and mechanisms underlying these Ca(2+)-dependent pathways are incompletely understood. Here we show that homozygous male mice with a targeted gene deletion of isoform 4 of the plasma membrane calcium/calmodulin-dependent calcium ATPase (PMCA), which is highly enriched in the sperm tail, are infertile due to severely impaired sperm motility. Furthermore, the PMCA inhibitor 5-(and-6)-carboxyeosin diacetate succinimidyl ester reduced sperm motility in wild-type animals, thus mimicking the effects of PMCA4 deficiency on sperm motility and supporting the hypothesis of a pivot…

MaleTime FactorsBiochemistryMiceTestisProtein IsoformsCloning MolecularCation Transport Proteinsreproductive and urinary physiologySperm motilityMice KnockoutRecombination GeneticReverse Transcriptase Polymerase Chain ReactionPlasma Membrane Calcium-Transporting ATPasesFluoresceinsTransport proteinCell biologyBlotting SouthernBiochemistrySperm Motilityendocrine systemDNA ComplementaryGenotypeBlotting WesternMolecular Sequence Datachemistry.chemical_elementSuccinimidesCalcium-Transporting ATPasesFertilization in VitroCalciumBiologyPlasma Membrane Calcium-Transporting ATPasesAnimalsHumansMolecular BiologyFluorescent DyesCalcium metabolismModels Geneticurogenital systemCell BiologyBlotting NorthernSpermProtein Structure TertiaryRatsCalcium ATPaseAlternative SplicingFertilitychemistryMicroscopy FluorescencePlasma membrane Ca2+ ATPaseCalciumThe Journal of biological chemistry
researchProduct

A Microassay for Measuring Glycogen in 96-Well-Cultured Cells

1996

Abstract This study describes a rapid, sensitive, and automated spectrophotometric enzymatic microassay that measures the intracellular glycogen of primary cultured hepatocytes and other cultured cells in 96-well plates and can be adapted for other samples that are transferred to these plates. The procedure involves in situ disruption of cells, followed by hydrolysis of glycogen into glucosyl units by fungal glucoamylase (exo-1,4-α- D -glucosidase, EC 3.2.1.3), and glucose determination with the glucose oxidase colorimetric method. The color intensity can be measured in conventional ELISA readers, and the data can be fed to an on-line computer for rapid processing. The advantages of this me…

MaleTime FactorsBiophysicsSensitivity and SpecificityBiochemistryRats Sprague-DawleyHydrolysischemistry.chemical_compoundCarbohydrate ConformationAnimalsGlucose oxidaseMolecular BiologyCells CulturedSample handlingchemistry.chemical_classificationChromatographybiologyGlycogenHydrolysisMicrochemistryfungiColor intensityRapid processingReproducibility of Resultsfood and beveragesDNACell BiologyLiver GlycogenRatsGlucoseEnzymeLiverBiochemistrychemistrybiology.proteinColorimetryGlucan 14-alpha-GlucosidaseIntracellularAnalytical Biochemistry
researchProduct

Noninvasive blood pressure monitoring evaluation of verapamil slow-release 240-mg antihypertensive effectiveness

1989

The aim of our study was to evaluate the antihypertensive effectiveness of verapamil slow-release (SR), administered once a day. We studied 11 patients, 7 male and 4 female, with an average age of 53.6 +/- 12.86 years, who had essential hypertension. After a drug washout period of at least 15 days, placebo was administered (one tablet per day), and then patients received verapamil SR 240 mg/day at 8:00 a.m. for at least 2 weeks. At the end of the washout, placebo, and active drug treatment periods we performed ambulatory intermittent blood pressure monitoring for 24 h using a Squibb Spacelabs pressurometer. After verapamil treatment, in comparison to placebo, a significant reduction of syst…

MaleTime FactorsBlood PressurePlaceboEssential hypertensionHeart RateHeart ratemedicineHumansCircadian rhythmMonitoring PhysiologicPharmacologybusiness.industryWashoutBlood Pressure DeterminationMiddle Agedmedicine.diseaseCircadian RhythmBlood pressureVerapamilEvaluation Studies as TopicDelayed-Action PreparationsAnesthesiaHypertensionAmbulatoryVerapamilFemaleCardiology and Cardiovascular Medicinebusinessmedicine.drug
researchProduct

Valve prosthesis-patient mismatch: hemodynamic, echocardiographic and clinical consequences

2011

OBJECTIVES: The purpose is to evaluate in vivo at rest and under stress conditions hemodynamic performance of the small size St. Jude Medical Regent (SJMR) prosthetic valve in patients with a body surface area (BSA) of 1.8 ± 0.11 m(2) and to define the role of valve prosthesis- patient mismatch on left ventricular mass regression following aortic valve replacement. METHODS: We evaluated 25 cases (12 males and 13 females, mean age 65.2 ± 8 years) of aortic valve replacement (17 mm SJMR in three cases and 19 mm SJMR in 22 cases). All the patients underwent at rest Doppler echocardiography before and after surgery and both basal and dobutamine stress echocardiography (DSE) at follow-up. The me…

MaleTime FactorsBody Surface Areamedicine.medical_treatmentLeft ventricular maHemodynamicsDoppler echocardiographyVentricular Function LeftValve replacementAortic valve replacementDobutamineCardiac skeletonBody surface areaHeart Valve Prosthesis ImplantationEjection fractionmedicine.diagnostic_testVentricular RemodelingMiddle AgedEchocardiography DopplerTreatment OutcomeAortic ValveHeart Valve ProsthesisCardiologyFemaleHypertrophy Left VentricularCardiology and Cardiovascular MedicineEchocardiography StressPulmonary and Respiratory Medicinemedicine.medical_specialtyProsthesis DesignPreoperative carePredictive Value of TestsInternal medicineProsthesis-patient mismatch; Left ventricular mass; Effective orifice area; DobutaminemedicineHumansAgedRetrospective StudiesChi-Square Distributionbusiness.industryHemodynamicsProsthesis-patient mismatchStroke VolumeSettore MED/23 - Chirurgia CardiacaAortic Valve StenosisRecovery of Functionmedicine.diseaseEffective orifice areaSurgerybusiness
researchProduct

Neuroprotection by erythropoietin administration after experimental traumatic brain injury.

2007

A large body of evidence indicates that the hormone erythropoietin (EPO) exerts beneficial effects in the central nervous system (CNS). To date, EPO's effect has been assessed in several experimental models of brain and spinal cord injury. This study was conducted to validate whether treatment with recombinant human EPO (rHuEPO) would limit the extent of injury following experimental TBI. Experimental TBI was induced in rats by a cryogenic injury model. rHuEPO or placebo was injected intraperitoneally immediately after the injury and then every 8 h until 2 or 14 days. Forty-eight hours after injury brain water content, an indicator of brain edema, was measured with the wet-dry method and bl…

MaleTime FactorsBrain EdemaFunctional LateralityRats Sprague-Dawleychemistry.chemical_compoundTraumatic brain injuryMedicineAnalysis of Variance Animals Blood-Brain Barrier; drug effects Brain Edema; drug therapy/etiology Brain Infarction; drug therapy/etiology Brain Injuries; complications/drug therapy Disease Models; Animal Erythropoietin; administration /&/ dosage Evans Blue; diagnostic use Functional Laterality Humans Male Neurologic Examination Neuroprotective Agents; administration /&/ dosage Rats Rats; Sprague-Dawley Reaction Time; drug effects Recombinant Proteins Time Factorsadministration /&/ dosageSpinal cord injuryEvans BlueNeurologic ExaminationGeneral Neuroscienceexperimental models of brain and spinal cord injuryExtravasationNeuroprotectionRecombinant Proteinsmedicine.anatomical_structureNeuroprotective AgentsBlood-Brain BarrierAnesthesiadiagnostic usemedicine.drugEvans BlueBrain InfarctionTraumatic brain injuryCentral nervous systemrecombinant human EPO (rHuEPO)PlaceboNeuroprotectionReaction TimeAnimalsHumansMolecular BiologyErythropoietinAnalysis of VarianceNeuroscience (all)business.industryAnimaldrug therapy/etiologymedicine.diseaseRatsDisease Models AnimalchemistryErythropoietindrug effectsBrain InjuriesDisease Modelsrecombinant human EPO (rHuEPO); experimental models of brain and spinal cord injury; NeuroprotectionNeurology (clinical)Sprague-Dawleybusinesscomplications/drug therapyDevelopmental BiologyBrain research
researchProduct

A critical period for experience-dependent remodeling of adult-born neuron connectivity.

2015

Neurogenesis in the dentate gyrus (DG) of the adult hippocampus is a process regulated by experience. To understand whether experience also modifies the connectivity of new neurons, we systematically investigated changes in their innervation following environmental enrichment (EE). We found that EE exposure between 2-6 weeks following neuron birth, rather than merely increasing the number of new neurons, profoundly affected their pattern of monosynaptic inputs. Both local innervation by interneurons and to even greater degree long-distance innervation by cortical neurons were markedly enhanced. Furthermore, following EE, new neurons received inputs from CA3 and CA1 inhibitory neurons that w…

MaleTime FactorsCIENCIAS MÉDICAS Y DE LA SALUDNeurogenesisNeuroscience(all)NeurocienciasSynaptogenesisHippocampusMice TransgenicHippocampal formationEnvironmentMotor ActivityInhibitory postsynaptic potentialTransfectionCRITICAL PERIODADULT NEUROGENESISArticleMiceNeural PathwaysmedicineAnimalsSYNAPTOGENESISCells CulturedNeuronsEnvironmental enrichmentNeuronal PlasticityGeneral NeuroscienceDentate gyrusCritical Period PsychologicalNeurogenesisBrain//purl.org/becyt/ford/3.1 [https]Embryo MammalianMice Inbred C57BLENRICHED ENVIRONMENTLuminescent ProteinsMedicina Básicamedicine.anatomical_structurenervous system//purl.org/becyt/ford/3 [https]NeuronNerve NetPsychologyNeuroscience
researchProduct

Task force on 'Early markers of atherosclerosis: influence of age and sex'

2013

Atherosclerosis and its complications are the most important causes of death all over the world, especially in Western countries. Diet habits, modern stress life, smoking, sedentary way of life and an involvement of genetic pattern of individuals lead to a sure degeneration of quality of life increasing the risk of atherosclerosis development. For this reason, the main purpose of actual medicine is to identify all the markers that could allow the physicians to evaluate the first moments of the development of this dangerous pathological process. The aim is to reduce the speed of its evolution, trying to delay indefinitely the risk coming from the morphological alterations of the vessels. 'En…

MaleTime FactorsCarotid Intima-Media ThicknessSex FactorsVascular StiffnessPredictive Value of TestsRisk FactorsHumansAorta AbdominalEarly markers of atherosclerosis age sexAge FactorsbiomarkersGenderatherosclerosis; gender differencesPrognosisSettore MED/11 - Malattie Dell'Apparato CardiovascolareVasodilationEarly Diagnosisatherosclerosis; biomarkers; Gender; ageingageingDisease ProgressionFemaleEndothelium VascularatherosclerosisDilatation Pathologic
researchProduct

Continuous intra-amygdalar infusion of GABA in the amygdala kindling model of epilepsy in rat.

2003

Objective: To explore the effect of continuous intra-amygdalar infusion of GABA in the amygdala kindling model of epilepsy in rat. Methods: An electrode and cannula complex was implanted in adult male Wistar rats, the electrode being targeted to the left basolateral amygdala. The animals were subjected to a standard kindling procedure. Osmotic minipumps filled with either GABA or mannitol were connected to cannulas and allowed to infuse during 7 days. Kindling experiments measuring after-discharge and seizure thresholds, seizure severity and duration, and behavioral toxicity were performed before, during and after the drug infusion period. Results: Both after-discharge and seizure threshold…

MaleTime FactorsCentral nervous systemPharmacologyAmygdalachemistry.chemical_compoundEpilepsyBasal gangliamedicineKindling NeurologicAnimalsRats WistarNeurotransmittergamma-Aminobutyric AcidEpilepsyDose-Response Relationship Drugbusiness.industryKindlingInfusion Pumps Implantablemedicine.diseaseAmygdalaElectric StimulationRatsDisease Models Animalmedicine.anatomical_structurenervous systemNeurologychemistryAnesthesiaToxicityAnticonvulsantsNeurology (clinical)businessBasolateral amygdalaEpilepsy research
researchProduct